Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Fatigue 7Neoplasms 4Brain Neoplasms 3Depression 2Asthenia 2Recurrence 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Neoplasm Metastasis 1Meningioma 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Gastrointestinal Neoplasms 1Ependymoma 1Central Nervous System Neoplasms 1Breast Neoplasms 1Astrocytoma 1

Interventions

Radiotherapy 19Vincristine 12Lomustine 11Temozolomide 9Procarbazine 8Cisplatin 7Carboplatin 7Etoposide 5Cyclophosphamide 5Chemotherapy, Adjuvant 5Granulocyte Colony-Stimulating Factor 4Filgrastim 4Carmustine 4etoposide phosphate 3Thiotepa 2Surgical Procedures, Operative 2Radiosurgery 2Peripheral Blood Stem Cell Transplantation 2Neoadjuvant Therapy 2Methotrexate 2Isotretinoin 2Ifosfamide 2Early Intervention, Educational 2Dihematoporphyrin Ether 2DNA Methylation 2sodium thiosulfate 1Thioguanine 1Restraint, Physical 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Central Nervous System Neoplasms × Methylphenidate × Clear all
NCT00031798 2021-09-09

Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors

Wake Forest University Health Sciences

Phase 3 Terminated
CNSSarcoma

Astrocytoma, Brain Neoplasms, Depression, Ependymoma, Fatigue, Glioblastoma, Glioma, Meningioma, Oligodendroglioma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡